Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Oil & Gas, Consumer Services and Financials sectors propelled shares higher. At the close in NYSE, the...
Cardinal Health (NYSE: CAH) reported fourth-quarter adjusted earnings today that were only two-thirds of what The Street expected. The Company posted an adjusted EPS of $0.77, behind...
Shares of Cardinal Health Inc. tumbled 13.7% toward a nine-month low in afternoon trading Thursday, after the distributor of drugs and laboratory products reported a big fiscal...
Investing.com - Cardinal Health (NYSE:CAH) reported on Thursday fourth quarter {{erl-7874||earnings that missed analysts' forecasts and revenue that topped expectations. Cardinal Health...
Cardinal Health (CAH): Q4 Non-GAAP EPS of $0.77 misses by $0.43; GAAP EPS of $0.40 misses by $0.14.Revenue of $42.6B (+16.1% Y/Y) beats by $2.35B.Fiscal 2022 guidance: Non-GAAP...
Cardinal Health (CAH) is scheduled to announce Q4 earnings results on Thursday, August 5th, before market open.The consensus EPS Estimate is $1.20 (-46.2% Y/Y) and the consensus...
By Geoffrey Smith Investing.com -- Global markets stabilize after Monday's sell-off - except for crypto, which is still falling after breaking some key support levels. The massive...
Shares of McKesson Corp. , Cardinal Health Inc. and AmerisourceBergen Corp. all surged more than 4% in morning trading Tuesday, after the New York Attorney General Letitia James announced...
Cardinal Health (CAH) announced that the FDA has approved LYMPHOSEEK (technetium Tc 99mtilmanocept) for pediatric use.LYMPHOSEEK, a radioactive diagnostic agent is the first
This move is a reversal from the hour prior, which saw price move up. The post Cardinal Health Inc (CAH): Price Down $-0.2 (-0.35)% Over Past Day, Down $-0.53 (-0.89)% Over Past Hour...
Investing.com – U.S. equities were mixed at the close on Monday, as gains in the Healthcare, Technology and Utilities sectors propelled shares higher while losses in the Basic Materials,...
This is a reversal of the price action on the previous day, in which price moved down. The post Cardinal Health Inc (CAH): Price Now Near $56.66; Daily Chart Shows An Uptrend on 50 Day Basis...
Cardinal Health’s valuation discount exists for a reason: BairdCardinal Health (CAH) is trading flat in the pre-market after Baird analyst Eric Coldwell downgraded the stock...
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Telecoms, Financials and Basic Materials sectors propelled shares higher. At the close in NYSE, the Dow...
Investing.com - Cardinal Health (NYSE:CAH) reported on Thursday third quarter {{erl-7874||earnings that missed analysts' forecasts and revenue that fell short of expectations. Cardinal...
More manufacturers and suppliers are scaling up the use of tracking technology to ensure critical medical shipments arrive on time and intact.
Shares of Cardinal Health rose almost 3% on Friday to close at $57.35 after the healthcare company announced the sale of its Cordis business to Hellman & Friedman (H&F), a private equity...
Cardinal Health Inc (NYSE: CAH) has agreed to sell its Cordis business to Hellman & Friedman, a private equity firm, for approximately $1 billion. The deal value includes the buyer's...
Cardinal Health Inc. announced Friday an agreement to sell its minimally invasive cardiovascular technology business Cordis for about $1 billion to Hellman & Friedman. Shares of the...
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about...
Investing.com – U.S. equities were higher at the close on Monday, as gains in the Oil & Gas, Industrials and Basic Materials sectors propelled shares higher. At the close in NYSE, the Dow...
Investing.com - Cardinal Health (NYSE:CAH) reported on Friday second quarter {{erl-7874||earnings that beat analysts' forecasts and revenue that topped expectations. Cardinal Health...
Cardinal Health (NYSE:CAH) is scheduled to announce Q2 earnings results on Friday, February 5th, before market open.The consensus EPS Estimate is $1.45 (-4.6% Y/Y) and the consensus...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
